Population Health Management for Inflammatory Bowel Disease Parambir S. Dulai, Siddharth Singh, Lucilla Ohno-Machado, William J. Sandborn Gastroenterology Volume 154, Issue 1, Pages 37-45 (January 2018) DOI: 10.1053/j.gastro.2017.09.052 Copyright © 2018 AGA Institute Terms and Conditions
Figure 1 Population health management components and strategy in IBDs. AGA, American Gastroenterology Association; CCF, Crohn’s and Colitis Foundation; IT, information technology; NLP, Natural Language Processing; PRO, Patient Reported Outcomes. Gastroenterology 2018 154, 37-45DOI: (10.1053/j.gastro.2017.09.052) Copyright © 2018 AGA Institute Terms and Conditions
Figure 2 Determinants of IBD health, variations in care, and future considerations. AZA, azathioprine; Chromo, chromoendoscopy or other dye-based surveillance techniques; C. Diff, Clostridium difficile; CMV, cytomegalovirus; Hep B, hepatitis B; 6MP, 6-mercaptopurine; TB, tuberculosis; TNF, tumor necrosis factor; TPMT, thiopurine methyltransferase test; VTE, venous thromboembolism. Gastroenterology 2018 154, 37-45DOI: (10.1053/j.gastro.2017.09.052) Copyright © 2018 AGA Institute Terms and Conditions